Communiqués Cytosorbents Corporation

Actions

CTSO

US23283X2062

Equipement et technologie médicale avancés

Temps Différé Nasdaq 22:00:00 02/07/2026 Varia. 5j. Varia. 1 janv.
0,3900 USD -0,26% Graphique intraday de Cytosorbents Corporation -15,22% -38,99%

Communiqués

18/06 CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026 AQ
14/05 Cytosorbents : Press Release (ctso q126 earnings press release 5 13 26 final one for distribution) PU
14/05 Cytosorbents : Presentation (ctso q1 2026 earnings presentation 5 13 26 final one final) PU
13/05 CytoSorbents: Q1 Earnings Snapshot AQ
13/05 CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update PR
30/04 CytoSorbents : to Report First Quarter 2026 Financial Results and Recent Business Highlights PU
07/04 Cytosorbents : Investor Presentation (cytosorbents investor presentation april 2026 website) PU
25/03 CytoSorbents: Q4 Earnings Snapshot AQ
12/01 Cytosorbents : Investor Presentation (cytosorbents investor presentation january 2026 final) PU
18/11 CytoSorbents to Present at the Jefferies Global Healthcare Conference in London AQ
15/11 Cytosorbents : Presentation (ctso 3q25 earnings presentation 11 13 25 final) PU
13/11 CytoSorbents: Q3 Earnings Snapshot AQ
12/11 CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London AQ
31/10/25 CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights AQ
26/09/25 Cytosorbents : Investor Presentation (cytosorbents investor presentation october 2025 website 2) PU
26/09/25 CytoSorbents : Leads a New Era in Sepsis Treatment (cytosorbents leads new era in sepsis treatment white paper september 2025) PU
25/09/25 Cytosorbents : Investor Presentation (cytosorbents investor presentation september 2025) PU
24/09/25 Cytosorbents : Investor Presentation (cytosorbents hcw presentation 9 8 25 final) PU
24/09/25 CytoSorbents : Leads a New Era in Sepsis Treatment (cytosorbents leads a new era in sepsis treatment 7 31 25) PU
27/08/25 Cytosorbents : Presentation (cytosorbents q2 2025 earnings presentation 8 7 25 final one) PU
20/08/25 CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR PR
07/08/25 CytoSorbents: Q2 Earnings Snapshot AQ
07/08/25 CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update PR
31/07/25 CytoSorbents Leads a New Era in Sepsis Treatment PR
29/07/25 CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights PR
Aucun résultat pour cette recherche